{"subsection_name": "Money &amp; Policy", "pub_date": "2011-10-18T15:04:17Z", "byline": {"original": "By ANDREW POLLACK", "person": [{"lastname": "POLLACK", "organization": "", "rank": 1, "role": "reported", "firstname": "Andrew"}]}, "abstract": "Advocates are concerned that a noninvasive test to determine if a fetus has Down syndrome will lead to more pregnancies being terminated.", "word_count": "587", "print_page": null, "news_desk": null, "snippet": "Advocates are concerned that a noninvasive test to determine if a fetus has Down syndrome will lead to more pregnancies being terminated.", "multimedia": [], "source": "The New York Times", "blog": [], "keywords": [], "type_of_material": "Blog", "lead_paragraph": null, "web_url": "http://prescriptions.blogs.nytimes.com/2011/10/18/the-quandary-posed-by-a-new-down-syndrome-test/", "section_name": "Health", "headline": {"main": "The Quandary Posed by a New Down Syndrome Test", "kicker": "Prescriptions Blog"}, "slideshow_credits": null, "_id": "54f3bc6c38f0d84018917909", "document_type": "blogpost"}